SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-247855
Filing Date
2021-08-16
Accepted
2021-08-16 16:41:37
Documents
17
Period of Report
2021-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d127312d8k.htm   iXBRL 8-K 28215
2 EX-10.1 d127312dex101.htm EX-10.1 152399
3 EX-99.1 d127312dex991.htm EX-99.1 11781
7 GRAPHIC g127312g0816232422302.jpg GRAPHIC 39536
8 GRAPHIC g127312g0816232423097.jpg GRAPHIC 44259
9 GRAPHIC g127312g0816233159819.jpg GRAPHIC 2491
  Complete submission text file 0001193125-21-247855.txt   487361

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA oric-20210812.xsd EX-101.SCH 2898
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20210812_lab.xml EX-101.LAB 18888
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20210812_pre.xml EX-101.PRE 11864
10 EXTRACTED XBRL INSTANCE DOCUMENT d127312d8k_htm.xml XML 3486
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 211179135
SIC: 2834 Pharmaceutical Preparations